Well, it’s nearly May and as everyone in Chicago knows, brutal winters finally come to an end (although this one was relatively mild), the grass greens up and the trees begin to sprout their foliage. As people plan their summer…continue reading →
On March 23rd of this year, the Affordable Care Act dubbed “Obamacare” reached its sixth year as the law of the land. From the laughably long waits to sign up, and the whiz kids from silicon valley who rescued the…continue reading →
Unless you have been hibernating in a cave, you have to have seen the massive swan dive into near oblivion that is Valeant Pharmaceuticals. What is most tragic is that Valeant has taken down a few notable portfolio managers with…continue reading →
If you’re wondering why Theranos’ results are yet the subject of debate, let’s start with three questions: Does Elizabeth Holmes’ technology actually work (i.e. where is the science / proof)? Does Theranos still hold the promise of a $9 billion…continue reading →
In Sickness & Wealth
Sometimes we fail to deliver better healthcare, not because a treatment doesn’t exist or science can’t develop one, but because it can’t survive the logistics of access, delivery, and sustainability. Good business is investing in activities that can achieve both... In Sickness and Wealth... as we explore innovative companies and how they deliver value.
David Lerman / Jodie Warner - Editors